Semaglutide Tied to Fewer Asthma, COPD Exacerbations
The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
Medibyt's CPETWise automated platform aims to cut cardiopulmonary exercise testing interpretation time in half and standardize clinical workflows.
California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.